إعلان
إعلان

PHAR

PHAR logo

Pharming Group N.V. ADS, each representing 10 ordinary shares

18.63
USD
برعاية
+0.74
+4.14%
٠٩ يناير, ١٥:٣٣ UTC -5
مغلق
exchange

بعد الإغلاق

18.45

-0.18
-0.97%

تقارير أرباح PHAR

النسبة الإيجابية المفاجئة

PHAR تفوق 20 من 39 آخر التقديرات.

51%

التقرير التالي

بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$104.74M
/
$0.00
التغير الضمني من Q3 25 (Revenue/ EPS)
+7.65%
/
-100.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+13.02%
/
--

Pharming Group N.V. ADS, each representing 10 ordinary shares earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, PHAR reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of 0.00 USD, resulting in a 1100.00% surprise. Revenue reached 97.30 مليون, compared to an expected 96.23 مليون, with a 1.11% difference. The market reacted with a +11.53% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of 0.00 USD, with revenue projected to reach 104.74 مليون USD, implying an نقصان of -100.00% EPS, and زيادة of 7.65% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Pharming Group N.V. ADS, each representing 10 ordinary shares reported EPS of $0.01, beating estimates by 1100%, and revenue of $97.30M, 1.11% above expectations.
The stock price moved up 11.53%, changed from $13.18 before the earnings release to $14.70 the day after.
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
Based on 6 المحللين, Pharming Group N.V. ADS, each representing 10 ordinary shares is expected to report EPS of -- and revenue of $104.74M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان